Timing is Everything: Early Chemotherapy Boosts Colorectal Cancer Survival
Study finds starting chemotherapy within 6 weeks after colorectal cancer surgery improves survival rates.
Pancreatic Cancer
2 articles
Epigenetic-Immunotherapy Combo Shows Promise in Advanced Pancreatic Cancer
Phase 2 trial combines HDAC inhibitor and PD-1 inhibitor in pancreatic cancer, showing durable responses.
Genetic Variants Linked to Higher Mortality Risk in Cancer Chemotherapy
Meta-analysis reveals DPYD gene variants significantly increase death risk in fluoropyrimidine chemotherapy.